The Phase I/II study will enrol approximately 368 adults aged 18 years and above.
The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus FamilyNext-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle ...
The administration of vaccination in Australia allows all adults who have not been infected with the virus or received a booster within the past six months to get an additional dose.
Parents asked questions, of course, but the underlying trust was there and vaccines were seen as part of the basic social ...
Adrian Esterman receives funding from the NHMRC, MRFF and ARC. COVID rarely rates a mention in the news these days, yet it hasn’t gone away. SARS-CoV-2, the virus that causes COVID, is still with us.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results